Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.90
-$0.08 (-1.00%)
Pre-market:
Sep 22, 2026, 5:48 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -312.76M | -547.03M | -892.87M | -2.11B | -1.84B | -126.72M |
Depreciation & Amortization | 58.99M | 63.02M | 71.55M | 42.55M | 29.08M | 13.86M |
Stock-Based Compensation | 81.55M | 112.34M | 229.88M | 1.93B | 1.61B | 476K |
Other Working Capital | -39.62M | -89.72M | -19.05M | -81.35M | 55.43M | -16.57M |
Other Non-Cash Items | 46.62M | 142.69M | 266.9M | -67.4M | -20.95M | 3.07M |
Deferred Income Tax | -1.36M | -936K | -801K | -14.61M | 30.21M | n/a |
Change in Working Capital | -44.09M | -89.67M | 29.84M | -37.01M | -61.54M | -26.52M |
Operating Cash Flow | -171.06M | -319.59M | -295.5M | -252.2M | -253.82M | -135.83M |
Capital Expenditures | -7.67M | -62.54M | -40.8M | -52.27M | -56.52M | -57.82M |
Cash Acquisitions | n/a | -5.4M | -38.55M | 26.65M | -12.04M | n/a |
Purchase of Investments | -418.63M | n/a | n/a | -3.69M | -5M | n/a |
Sales Maturities Of Investments | 185.38M | 4.52M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 624K | 1.19M | -1.34M | -38.08M | 304K | -9.3M |
Investing Cash Flow | -240.29M | -62.24M | -80.69M | -67.39M | -73.26M | -67.12M |
Debt Repayment | -354K | -897K | -1.3M | -1.24M | -1.12M | -748K |
Common Stock Repurchased | n/a | n/a | -23K | n/a | -25M | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.34M | -922K | -1.43M | -2.73M | 1.56B | 26K |
Financial Cash Flow | 17.78M | -1.74M | -3.22M | 95.34M | 1.53B | 90.32M |
Net Cash Flow | -393.18M | -383.84M | -380M | -223.35M | 1.21B | -112.63M |
Free Cash Flow | -178.72M | -382.13M | -336.3M | -304.47M | -310.34M | -193.65M |
Adj. Free Cash Flow | -260.27M | -494.47M | -566.19M | -2.24B | -1.92B | -194.13M |
Maintenance CapEx | -7.67M | -62.54M | -40.8M | n/a | n/a | -26.12M |
Growth CapEx | n/a | n/a | n/a | -52.27M | -56.52M | -31.7M |
Owner Earnings | -178.72M | -382.13M | -336.3M | -252.2M | -253.82M | -161.95M |
Add to Watchlist
Select watchlists to add or remove DNA